-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Neutral on Co-Diagnostics, Lowers Price Target to $1

Benzinga·03/28/2025 17:50:20
Listen to the news
HC Wainwright & Co. analyst Yi Chen maintains Co-Diagnostics (NASDAQ:CODX) with a Neutral and lowers the price target from $1.5 to $1.